Application of chitosan-based nanogels for dermal and transdermal delivery systems Authors: Ahmadreza Soroush Fard, Zahra Sabouri, Majid Darroudi, Roghaye Arezumand Published: 2025 ABSTRACT We review the utilization of chitosan-based nanogels as advanced vehicles for dermal drug delivery. Dermal delivery allows local treatment with a simple application for the patient, while also providing an alternative route that avoids gastrointestinal degradation and first-pass metabolism to help reduce doses and systemic side effects. Nanogels are nanoscale hydrogel networks that preserve the drug-loading capacity and tunable release characteristics of hydrogels, while retaining the colloidal stability of nanoparticles. The addition of chitosan into nanogels provides bioadhesive and permeability-enhancing characteristics; for example, chitosan’s positive charge promotes adhesion to negatively charged skin and can transiently open tight junctions to improve uptake of drugs. Chitosan nanogels exhibit higher drug encapsulation efficiency and more controlled release than conventional topical or bulk gels, and improved penetration into biological membranes due to their small size and surface charge. Chitosan nanogels can be prepared by various methods, including via ionic gelation (electrostatic crosslinking), emulsification (with emulsion polymerization), self-assembly, and radical (covalent) polymerization. These systems have been investigated in dermatology, skin care, cosmetics, and dermal cancer therapy. Overall, chitosan nanogels represent a unique and versatile platform in which mucoadhesion, biocompatibility, and permeation enhancement can collectively improve the efficacy and safety of topical and transdermal therapies. Introduction The skin is the largest organ in the body and provides an excellent protective barrier, thereby limiting the absorption of drugs and pathogens, and foreign substances [1, 2]. The stratum corneum (SC) is the outermost layer of the epidermis that provides the primary barrier function. It is composed of dead keratin-filled cells, which are embedded in a lipid-rich matrix to protect against external substances [3]. Delivering therapeutics through the skin (i.e., dermal or transdermal administration) can be very beneficial. Topically delivered drugs avoid gastrointestinal degradation and first-pass metabolism, enabling them to act directly at the target site [1, 4, 5]. Dermal therapy can provide fast local drug action with large local bioavailability (for example, for wound healing or the treatment of skin infections). Many drugs exhibit low efficiency because they are lost by dissolution before reaching their desired target sites. Nanogels offer controlled and targeted drug release, enhance drug permeation, and minimize toxicity to healthy cells [1, 4, 6]. Traditional topical formulations (ointments, creams, gels, films…) are acceptable, but they are often limited in skin penetration and their ability to control release. For traditional designs, nanoscale carriers have partially alleviated the limitations of skin delivery. Nanoscale formulations-particularly nanogel systems-have superior dermal delivery based on their small size and modified performance parameters; they permit enhanced skin permeation and sustained release in comparison with traditional preparations [1, 7, 8]. Nanogels are either chemically or physically polymer networks. They have hydrogel properties (water content and biocompatibility) and nanoparticle properties (small size and customizable surface characteristics). Nanogels can absorb and retain large amounts of both hydrophilic and hydrophobic actives: large volumes of water, biological fluids, and a diverse range of therapeutics, including small molecules, proteins, and DNA/RNA, while maintaining structural integrity [9, 10]. Their nanoscale sizes provide relatively high surface area and substantial internal space, establishing drug stability and circulation times within the body. These systems effectively protect the payload until it reaches the specific target tissue or organ. Controlled or sustained drug release occurs in response to a specific reaction or bond cleavage within the nanogel [1, 9]. In dermal applications, the nanoscale and rheological behavior of nanogels all favor skin retention: they typically form a thin and spreadable film on skin and resist wash-off. In general, nanogel formulations often provide improved stability and longer drug release with lower risk of skin irritation compared to unstructured (bulk) gels [1, 11]. Another interesting feature is stimuli-responsive nanogels (e.g., pH- or thermo-sensitive), which can release drugs or provide on-demand controlled release [10, 12]. Chitosan nanogels: comparative advantages Chitosan nanogels possess a three-dimensional network with high internal volume and surface area, allowing exceptional drug-loading capacity compared to traditional gels. Their superior swelling ability further enhances water and drug absorption [10, 13]. Drug loading can occur via physical entrapment, covalent attachment, or self-assembly through polyelectrolyte interactions, depending on polymer composition, molecular weight, and functional groups [14]. Due to their small size (<200 nm), chitosan nanogels can penetrate intercellular spaces and accumulate within hair follicles, enhancing drug diffusion into deeper skin layers [6, 15]. They can distribute through both transcellular and paracellular pathways, resulting in improved epidermal and dermal deposition. Chitosan (CS) is a biodegradable, biocompatible, and non-toxic biopolymer widely used in biomedical and pharmaceutical applications [16–18]. N-acylated chitosan functions as an efficient carrier and sustained-release agent [19]. Chitosan’s innate antimicrobial activity, mucoadhesiveness, and solubility in acidic aqueous media make it particularly suitable for topical nanogels [1, 4, 20]. Its positive charge under neutral-to-acidic pH enables strong interactions with negatively charged skin components such as keratin and mucin, promoting tighter adhesion and enhanced drug permeation by loosening the stratum corneum structure [1, 21]. Chitosan’s degree of deacetylation and molecular weight significantly affect its permeation-enhancing ability, with higher values showing greater efficacy [4]. Its film-forming capacity creates a breathable protective barrier that retains moisture, prevents transepidermal water loss, and shields the skin from environmental irritants, thereby improving barrier function [22–25]. In topical formulations, chitosan-based nanogels demonstrate excellent safety and tolerability, producing minimal irritation compared with systems using harsh surfactants or solvents. Studies such as those on Mirtazapine-loaded chitosan hydrogels and levofloxacin chitosan systems confirmed their non-irritant nature and effective sustained delivery [1, 4, 26–29]. By adjusting polymer composition and cross-linking density, chitosan nanogels can be tailored to provide controlled and prolonged drug release, maintaining therapeutic levels for extended durations [1, 10]. Overall, chitosan’s multifunctional properties, biocompatibility, mucoadhesiveness, film formation, and controlled-release behavior make it an ideal polymer for designing advanced drug delivery systems [30–33]. The stratum corneum (SC), the outermost layer of the skin, acts as a key barrier to transdermal drug delivery. Transdermal nanogels are being explored for treating various conditions such as eczema, Parkinson’s disease, Alzheimer’s disease, depression, cardiac disorders, and skin cancer [6]. Recently, increasing interest has been directed toward localized drug-delivery systems that sustain therapeutic levels at targeted sites, such as the periodontal region, while minimizing systemic effects. Sustained-release formulations enable lower dosages with prolonged and localized therapeutic action [34]. Chitosan nanoparticles exist as natural biodegradable substances that offer better safety than synthetic cationic dendrimers, which show potential cytotoxic effects. Chitosan nanoparticles create a stable solid structure, which differs from liposomes because their phospholipid bilayer structure causes instability and early drug release. Dendrimers provide perfect monodispersity and extensive functionalization potential, but their manufacturing process stands in direct opposition to the straightforward, cost-effective production of chitosan. Chitosan provides two main benefits through its natural ability to stick to mucous membranes and its capacity to temporarily open tight junctions. This improves mucosal permeability, a characteristic that SLNs and polymeric micelles do not possess. The physical stability of chitosan against polymorphic transitions exists as a strength that SLNs sometimes lack. The main distinction between chitosan and PLGA nanoparticles as drug carriers emerges from chitosan’s natural antimicrobial effects, which synthetic PLGA nanoparticles do not possess. The main drawback of chitosan emerges from its poor solubility at physiological pH, but liposomes and dendrimers maintain stable performance throughout various pH levels, which demonstrates the trade-off between natural and synthetic materials. Synthesis methods Ionic gelation Ionic gelation employs polyelectrolytes and ions as a quick and easy process of NG formation. Ionic gelation is based on the attraction of oppositely charged molecules. In general, ionic gelation is performed by preparing ionic geometries from ionizable polymers such as chitosan, alginate, hyaluronic acid, or poly (glutamic acid). When ionic gelation occurs in aqueous environments, polymer chains are physically crosslinked with in situ changes in the properties of the polymer, such as pH, temperature, or ionic strength. In terms of pH, notable shifts can drive ionic bond formation between polymer chains [34]. Chitosan has unique properties that allow it to participate in ionic gelation. Under acidic conditions, typically when